Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 3:36 p.m.

    📋 AVADEL PHARMACEUTICALS PLC (AVDL) - Clinical Trial Update

    Filing Date: 2022-07-19

    Accepted: 2022-07-19 07:10:26

    Event Type: Clinical Trial Update

    Event Details:

    Avadel Pharmaceuticals (AVDL) Announces Clinical Trial Update Avadel Pharmaceuticals (AVDL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: listed, cataplexy
    • Diseases/Conditions: FDA’s Orange Book, 11 months or less
    • Collaboration: EDS

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Avadel Pharmaceuticals
    • CIK: 0001012477
    • Ticker Symbol: AVDL
    • Period End Date: 2022-07-19
    • Document Type: 8-K

Search

News categories